We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Three Drugmakers Share Exclusivity on Schizophrenia Drug Geodon
Three Drugmakers Share Exclusivity on Schizophrenia Drug Geodon
March 13, 2012
Dr. Reddy’s Laboratories, Apotex and Lupin Pharmaceuticals are launching generic versions of Pfizer’s blockbuster schizophrenia drug Geodon and the trio of generic-drug makers are expected to share the 180-day exclusivity as first filers.